This podcast was recorded on July 21, 2025. Tim Beyers: Is it time to buy biotech? You're listening to Motley Fool Money.

Keep in mind, though, that many steep dividend yields are due to the underlying stock having fallen, and Pfizer is a clear ...

Pfizer raised its earnings outlook slightly when it reported second-quarter earnings on Aug. 5, 2025. Upcoming losses of ...

Newcomers will not only be plugging into UPS while its forward-looking yield stands at 7.4%, but while the stock's priced ...

The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the ...

Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...

Pfizer's oncology pipeline looks promising. The company's newer approvals could make significant progress. And its efforts to ...

This technology juggernaut has been designing and selling state-of-the-art hardware and software solutions to businesses and individuals around the world for 50 years, but what makes it a good ...

Pfizer Inc. (NYSE:PFE) anticipates multiple key pipeline catalysts in 2025, including up to 9 Phase 3 readouts. Overall, PFE ranks 5th on our list of the best high volume stocks to buy now.

2. ExxonMobil is the industry giant That said, if you want to buy one company that covers a lot of ground in the energy sector, then industry giant ExxonMobil (NYSE: XOM) is probably a good call.